Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)

News provided by

Jul 11, 2011, 04:00 ET

NEW YORK, July 11, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0569837/Emerging-Markets-for-In-Vitro-Diagnostics-IVD-in-Brazil-Russia-India-China-and-Other-Nations.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

There is much discussion about emerging markets in in vitro diagnostics, especially the BRIC nations - Brazil, Russia, India and China. Which companies have been successful in these markets and how have they accomplished it? What kind of realistic growth can marketers expect by selling products in these areas? This report is intended to provide an overview of trends and developments in the in IVD industry as it applies to emerging markets and the BRIC countries in particular.

A Realistic Look at the Market for IVD in New, Emerging Markets

A good number of reports on the BRIC and emerging markets have been published. Most of these focus on quantitative data such as number of labs, hospitals, product registration regulations, and import taxes and conditions. Too many of them perhaps present merely a growth scenario without presenting the challenges the nations face and the challenges the countries face entering the market. This report provides much of this information because it provides an objective overview of the market for in vitro diagnostics in selected countries. This report also explores the opportunities that specific developing countries offer to IVD companies.

Kalorama also attempts to add some realistic aspects of working in a foreign country that are more qualitative in nature. Thus the report explores some of the cultural aspects of how the market for clinical diagnostics may evolve in a selection of emerging markets including the BRIC countries.

Useful Information for Business Planning

The discussion of each of the BRIC markets begins with a short introduction to the country and follows with a SWOT analysis of the market for IVDs. The SWOT analysis provides positive and negative aspects of market conditions. The author has decided to include positive and negative aspects of certain factors in the same SWOT category. The factors are classed positive or negative according to the strength of current market conditions. This is done to make the analysis comprehensive and easier to read.

The report covers data trends and issues, including:

Healthcare trends and metrics in each country
Physician Office Testing (POL) in BRIC Countries
Disease Trends (Diabetes, Cancer, Allergy, Emerging Viruses)
Lab Systems in BRIC Countries
SWOT Analysis for Each BRIC Nation, Including:
- Strengths - factors that make the country attractive for IVD companies
- Weaknesses that form barriers to entry and success such as health insurance coverage, regulatory affairs and distribution issues
- Country Elements that Provide Testing Opportunities
- Threats - a look at the competition and incumbents
Key Companies Operating in Each Country
Research and High Technology in BRIC countries
Other Trends (Insurance, Medical Tourism, Recession Effects )

Market and economic trends are discussed from the point of view of their present and potential impact and there is a focus on the mix of economics, healthcare and diagnostics that may evolve in these countries.

CHAPTER ONE: EXECUTIVE SUMMARY

Scope and Methodology
Emerging Market Trends
World Demand for Diagnostics

CHAPTER TWO: INTRODUCTION

Background
Population Trends and Disease Demographics
Disease Trends
- Diabetes
- Cancer
- Allergy
- Emerging Viruses
Market Segment Opportunities
- Physician Office Testing (POL)
- Lab Systems
- Research and High Technology
Insurance Trends
Medical Tourism
Recession Effects

CHAPTER THREE: OVERVIEW AND BRIC COMPARISON

Background
The BRIC Metrics
- Available Market
- Culture of Paying for Healthcare
- Capacity to Serve
IVD Spending
China and India - The BRIC Engines

CHAPTER FOUR: CHINA: MARKET TRENDS/DEMAND ANALYSIS

Introduction
Strengths - Factors That Make the Country Attractive
Weaknesses - Factors That Offer Barriers to Market Success and Entry
- Insurance
- Regulatory Affairs
- Distribution Issues
Opportunities - Elements That Provide Opportunity
Threats - competition and incumbent players
- The Market
- International IVD Companies
- Bayer Diabetes Care
- Biohit Oy
- Cogenics (now part of Danaher)
- Eiken Chemical Co., Ltc
- Fenwal, Inc.
- IRIS International, Inc.
- Luminex Corporation
- MedMira
- m-u-t AG
- PerkinElmer
- Phadia AB
- QIAGEN N.V.
- Quest Diagnostics
- Quintiles
- Roche Diagnostics
- SuperNova Diagnostics, Inc.
- China-based Companies
- Autobio Group
- Beijing Genome Institute (BGI)
- Bio-Asia Diagnostics
- CapitalBio Corporation
- Caretium Medical Instruments
- Chemtron Biotech Co. Ltd
- China Health Labs & Diagnostics Ltd.
- China Medical Technologies
- China Sky One Medical, Inc.
- Hai Kang Life Corporation
- Mindray Medical International Limited
- Motic
- ProGenTech Limited
- Runbio Biotech Co. Ltd.
- Shanghai Kehua Bio-Engineering
- Vita Genomics

CHAPTER FIVE: INDIA: MARKET TRENDS/DEMAND ANALYSIS

Introduction
Strengths - factors that make the country attractive
- No Centralized Decision Makers
- Insurance
- Regulatory Affairs
- Distribution Issues
Opportunities - elements that provide opportunity
Threats - competition and incumbent players
- The Market
- International IVD Companies
- Biomagnetics Diagnostics Corp.
- DiaGenic
- Novartis Diagnostics
- PerkinElmer
- Phadia AB
- QIAGEN N.V.
- Quest Diagnostics
- Quintiles
- Radient Pharmaceuticals Corp.
- India-Based Companies
- 3B BlackBio India Biotech
- Agappe Diagnostics
- AGD Biomedicals Pvt. Ltd.
- Avesthagen Limited
- Diagnova
- J.Mitra & Co. Pvt Ltd
- ROBONIK INDIA PVT LTD
- Span Diagnostics Ltd.
- Transasia Bio-Medicals Ltd.
- Trivitron Group
- The Tulip Group
- Vimta Labs

CHAPTER SIX: BRAZIL: MARKET TRENDS/DEMAND ANALYSIS

Introduction
Strengths - factors that make the country attractive
Weaknesses - factors that offer barriers to market success and entry
- Insurance
- Regulatory Affairs
- Distribution
Opportunities - elements that provide opportunity
Threats - competition and incumbent players
- The Market
- International IVD Companies
- Agendia B.V.
- AnaSpec, Inc.
- Axela Inc.
- Chembio Diagnostics Inc.
- Fluidigm Corporation
- Genomic Health, Inc.
- Hemagen Diagnostics, Inc
- Phadia AB
- Brazil-based Companies
- Bio-Manguinhos/FioCruz
- BIOTÉCNICA Indústria e Comércio Ltda
- CELM - Companhia Equipadora De Laboratorios Modernos
- Doles Reagentes
- Ebram Productos Laboratorias
- Gold Analisa
- Hemogram Indústria e Comercio de Produtos Hospitalares
- Katal Biotechnologica/Interteck
- Laborlab
- Wama Diagnostica

CHAPTER SEVEN: RUSSIA: MARKET TRENDS/DEMAND ANALYSIS

Introduction
Strengths - Factors that make the Country Attractive
Weaknesses - Factors that Offer Barriers to Market Success and Entry
- Insurance
- Regulatory Affairs
- Distribution Issues
Opportunities - Elements That Provide Opportunity
Threats - Competition and Incumbent Players
- The Market
- International IVD Companies
- Arrayit Corp.
- Biohit Oy
- Russia-based Strength
- Alkor Bio
- Biola
- Dialat Ltd.
- Evrogen JSC
- InterLabService Ltd. (ILS)
- Olveks Diagnostikum
- Technomedica
- Vital Diagnostics SPb
- Xema-Medica Co., Ltd.

CHAPTER EIGHT: NATIONS OTHER THAN BRIC

Introduction
Turkey
Poland
Nigeria

CHAPTER NINE: CONCLUSION

Introduction
Insurance
Intellectual Property Protection
Regulatory Affairs & Distribution
Market Opportunities

TABLE OF EXHIBITS